- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.13: 2 residues within 4Å:- Chain A: N.21, N.52
Ligand excluded by PLIPNAG.14: 4 residues within 4Å:- Chain A: N.113, T.115, N.116, V.118
Ligand excluded by PLIPNAG.15: 2 residues within 4Å:- Chain A: N.322, Q.571
Ligand excluded by PLIPNAG.16: 1 residues within 4Å:- Chain A: N.594
Ligand excluded by PLIPNAG.17: 3 residues within 4Å:- Chain A: N.607, T.609
- Chain B: Q.823
Ligand excluded by PLIPNAG.18: 1 residues within 4Å:- Chain A: N.648
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain A: N.696, G.1118
Ligand excluded by PLIPNAG.20: 4 residues within 4Å:- Chain A: A.693, E.1059, K.1060, N.1061
Ligand excluded by PLIPNAG.21: 4 residues within 4Å:- Chain A: N.1085, T.1087, H.1088, F.1090
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain A: N.156
- Chain C: I.459, T.461
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain A: E.272, N.273
- Chain C: K.549
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain A: N.334, V.358, S.362
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain A: C.6, N.8, N.128
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain B: N.21, N.52
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain B: N.113, T.115, N.116, V.118
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain B: N.322, Q.571
Ligand excluded by PLIPNAG.30: 1 residues within 4Å:- Chain B: N.594
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain B: N.607, T.609
- Chain C: Q.823
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain B: N.648
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain B: N.696, G.1118
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain B: A.693, E.1059, K.1060, N.1061
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain B: N.1085, T.1087, H.1088, F.1090
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain A: I.459, T.461
- Chain B: N.156
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain A: K.549
- Chain B: E.272, N.273
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain B: N.334, V.358, S.362
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain B: C.6, N.8, N.128
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain C: N.21, N.52
Ligand excluded by PLIPNAG.42: 4 residues within 4Å:- Chain C: N.113, T.115, N.116, V.118
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain C: N.322, Q.571
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain C: N.594
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain A: Q.823
- Chain C: N.607, T.609
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain C: N.648
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain C: N.696, G.1118
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain C: A.693, E.1059, K.1060, N.1061
Ligand excluded by PLIPNAG.49: 4 residues within 4Å:- Chain C: N.1085, T.1087, H.1088, F.1090
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain B: I.459, T.461
- Chain C: N.156
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain B: K.549
- Chain C: E.272, N.273
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain C: N.334, V.358, S.362
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain C: C.6, N.8, N.128
Ligand excluded by PLIP- 3 x BLA: BILIVERDINE IX ALPHA(Non-covalent)
BLA.26: 8 residues within 4Å:- Chain A: N.90, I.92, I.110, N.112, V.117, R.181, F.183, L.217
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:N.90, A:I.110, A:N.112, A:V.117, A:L.217, A:L.217
- Hydrogen bonds: A:N.112
- pi-Cation interactions: A:R.181, A:H.198
BLA.40: 8 residues within 4Å:- Chain B: N.90, I.92, I.110, N.112, V.117, R.181, F.183, L.217
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:N.90, B:I.110, B:N.112, B:V.117, B:L.217, B:L.217
- Hydrogen bonds: B:N.112
- pi-Cation interactions: B:R.181, B:H.198
BLA.54: 8 residues within 4Å:- Chain C: N.90, I.92, I.110, N.112, V.117, R.181, F.183, L.217
9 PLIP interactions:9 interactions with chain C- Hydrophobic interactions: C:N.90, C:I.110, C:N.112, C:V.117, C:L.217, C:L.217
- Hydrogen bonds: C:N.112
- pi-Cation interactions: C:R.181, C:H.198
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xiong, X. et al., A thermostable, closed SARS-CoV-2 spike protein trimer. Nat.Struct.Mol.Biol. (2020)
- Release Date
- 2020-07-22
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 3 x BLA: BILIVERDINE IX ALPHA(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xiong, X. et al., A thermostable, closed SARS-CoV-2 spike protein trimer. Nat.Struct.Mol.Biol. (2020)
- Release Date
- 2020-07-22
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C